GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (GREY:BVNXF) » Definitions » Additional Paid-In Capital

Bioventix (Bioventix) Additional Paid-In Capital : $1.87 Mil(As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Bioventix Additional Paid-In Capital?


Bioventix's quarterly additional paid-in capital increased from Dec. 2022 ($1.63 Mil) to Jun. 2023 ($1.86 Mil) and increased from Jun. 2023 ($1.86 Mil) to Dec. 2023 ($1.87 Mil).

Bioventix's annual additional paid-in capital declined from Jun. 2021 ($1.87 Mil) to Jun. 2022 ($1.64 Mil) but then increased from Jun. 2022 ($1.64 Mil) to Jun. 2023 ($1.86 Mil).


Bioventix Additional Paid-In Capital Historical Data

The historical data trend for Bioventix's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Additional Paid-In Capital Chart

Bioventix Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 1.65 1.87 1.64 1.86

Bioventix Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.64 1.63 1.86 1.87

Bioventix Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Bioventix Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bioventix's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioventix (Bioventix) Business Description

Traded in Other Exchanges
Address
East Street, 7 Romans Business Park, Farnham, Surrey, GBR, GU9 7SX
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.

Bioventix (Bioventix) Headlines

From GuruFocus

Urbem's 'Wonderful Business' Series: Bioventix

By Steven Chen Steven Chen 12-13-2019

Bond Proxies: Playing Defense for Alpha

By Steven Chen Steven Chen 07-05-2019